ProstaLund Overview

  • Founded
  • 1991
  • Status
  • Public
  • Employees
  • 7
  • Stock Symbol
  • PLUN
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.47
  • (As of Friday Closing)

ProstaLund General Information


Prostalund AB is a medical technology company engaged in development of products and treatments in urology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
Primary Office
  • Scheelevägen 19
  • 223 63 Lund
  • Sweden
+46 046-12 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ProstaLund Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.47 $0.46 $0.41 - $0.77 $24.3M 51.5M 50.1K -$0.03

ProstaLund Financials Summary

In Thousands,
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 29,560 12,318 8,439 5,536
Revenue 1,855 1,352 1,362 1,559
EBITDA (1,077) (1,057) (1,079) (1,444)
Net Income (1,102) (1,082) (1,119) (1,488)
Total Assets 4,881 3,759 2,822 2,131
Total Debt 34 73 86 89
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ProstaLund Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ProstaLund‘s full profile, request access.

Request a free trial

ProstaLund Patents

ProstaLund Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180132932-A1 Device for supply of heat to body tissue Abandoned 26-Feb-2015 00000000000 0
ES-2865027-T3 Device for supplying heat to body tissues Active 26-Feb-2015 00000000000
EP-3261568-B1 Device for supply of heat to body tissue Active 26-Feb-2015 00000000000
EP-3261568-A1 Device for supply of heat to body tissue Granted 26-Feb-2015 00000000000
EP-3261568-A4 Device for supply of heat to body tissue Granted 26-Feb-2015 A61B18/1815 0
To view ProstaLund’s complete patent history, request access »

ProstaLund Executive Team (5)

Name Title Board Seat Contact Info
Johan Wennerholm Chief Executive Officer & Managing Director
Göran Dybner Marketing & Sales Director
Charlotta Andersson Sales Manager and Clinical Instructor for Sweden and Finland
You’re viewing 3 of 5 executive team members. Get the full list »

ProstaLund Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProstaLund Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 05-Sep-2014 0000000000 00000 Pharmaceuticals
To view ProstaLund’s complete acquisitions history, request access »

ProstaLund Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000 & Pharmaceuticals Borås, Sweden 0000
To view ProstaLund’s complete subsidiaries history, request access »